Sumitomo Chemical (SOMMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,096,221 | 983,671 | 1,704,787 | 1,831,485 | 1,499,251 |
| Marketable Securities | 375,047 | 414,628 | 312,530 | 338,035 | 353,478 |
| Receivables | 3,954,044 | 3,718,748 | 3,754,562 | 3,690,172 | 3,869,440 |
| Inventories | 4,377,303 | 4,461,057 | 4,676,397 | 4,772,778 | 4,869,856 |
| Other current assets | 924,415 | 775,266 | 941,424 | 564,050 | 694,565 |
| TOTAL | $10,727,030 | $10,353,370 | $11,389,700 | $11,196,520 | $11,286,590 |
| Non-Current Assets | |||||
| PPE Net | 5,197,913 | 5,215,468 | 5,257,917 | 5,436,454 | 5,247,629 |
| Investments And Advances | 2,678,724 | 3,157,937 | 3,312,289 | 3,695,097 | 3,943,411 |
| Intangibles | 3,324,901 | 3,312,614 | 3,526,103 | 3,340,393 | 3,593,293 |
| Other Non-Current Assets | 950,012 | 934,491 | 1,194,541 | 1,249,066 | 1,207,417 |
| TOTAL | $12,151,550 | $12,620,510 | $13,290,850 | $13,721,010 | $13,991,750 |
| Total Assets | $22,878,590 | $22,973,890 | $24,680,550 | $24,917,540 | $25,278,340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,342,361 | 1,504,428 | 3,561,380 | 2,987,463 | 3,627,098 |
| Accounts payable and accrued liabilities | 3,252,610 | 3,306,259 | 3,469,297 | 3,534,987 | 3,611,757 |
| Other current liabilities | 1,675,676 | 1,706,156 | 1,884,821 | 1,798,990 | 1,805,389 |
| TOTAL | $6,341,871 | $6,625,235 | $9,210,828 | $8,618,009 | $9,347,808 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,760,981 | 7,107,511 | 5,967,060 | 7,024,923 | 6,092,793 |
| Other Non-Current Liabilities | 1,130,942 | 1,119,947 | 1,239,381 | 1,303,894 | 1,281,556 |
| TOTAL | $8,515,150 | $9,025,063 | $7,861,458 | $9,020,009 | $8,078,240 |
| Total Liabilities | $14,857,020 | $15,650,300 | $17,072,290 | $17,638,020 | $17,426,050 |
| Shareholders' Equity | |||||
| Common Shares | 613,217 | N/A | 594,389 | 603,395 | 575,603 |
| Retained earnings | 4,464,703 | 4,333,655 | 4,192,868 | 4,028,998 | 3,997,766 |
| Other shareholders' equity | 2,999,829 | 2,426,529 | 2,875,668 | 2,700,966 | 3,330,562 |
| TOTAL | $8,021,565 | $7,323,591 | $7,608,262 | $7,279,517 | $7,852,294 |
| Total Liabilities And Equity | $22,878,585 | $22,973,891 | $24,680,552 | $24,917,537 | $25,278,344 |